The impact of new chemotherapeutic and h
β
Stephen K. Chia; Caroline H. Speers; Yulia D'yachkova; Anna Kang; Suzanne Malfai
π
Article
π
2007
π
John Wiley and Sons
π
English
β 124 KB
π 1 views
## Abstract ## BACKGROUND. Over the past decade, a number of new therapeutic agents have become available in the treatment of metastatic breast cancer (MBC). This study characterized the use and assessed the impact on survival of populationβbased access to new agents for the treatment of MBC. ##